Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Miriam Gorostidi-Aicua

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Frontiers in Microbiology|April 10, 2025
A proposed workflow to robustly analyze bacterial transcripts in RNAseq data from extracellular vesiclesAlex M Ascensión, Miriam Gorostidi-Aicua, Ane Otaegui-Chivite, et al.
Plos One|April 7, 2021
O group is a protective factor for COVID19 in Basque populationMaider Muñoz-Culla, Andres Roncancio-Clavijo, Bruno Martínez, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|October 15, 2024
Microbiota modulation by teriflunomide therapy in people with multiple sclerosis: An observational case-control studyLaura Moles, Ane Otaegui-Chivite, Miriam Gorostidi-Aicua, et al.
Microorganisms|May 25, 2024
Bacteria-Fungi Interactions in Multiple SclerosisMiriam Gorostidi-Aicua, Iraia Reparaz, Ane Otaegui-Chivite, et al.
Frontiers in Immunology|November 3, 2022
Microbial dysbiosis and lack of SCFA production in a Spanish cohort of patients with multiple sclerosisLaura Moles, Susana Delgado, Miriam Gorostidi-Aicua, et al.
Frontiers in Immunology|August 12, 2025
Exploring the mycobiota in multiple sclerosis: its influence on disease development and progressionAne Otaegui-Chivite, Miriam Gorostidi-Aicua, Laura Martins-Almeida, et al.
Plos One|May 19, 2023
Early biochemical analysis of COVID-19 patients helps severity predictionAndrés Roncancio-Clavijo, Miriam Gorostidi-Aicua, Ainhoa Alberro, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Frontiers in Microbiology|April 10, 2025
A proposed workflow to robustly analyze bacterial transcripts in RNAseq data from extracellular vesiclesAlex M Ascensión, Miriam Gorostidi-Aicua, Ane Otaegui-Chivite, et al.
Plos One|April 7, 2021
O group is a protective factor for COVID19 in Basque populationMaider Muñoz-Culla, Andres Roncancio-Clavijo, Bruno Martínez, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|October 15, 2024
Microbiota modulation by teriflunomide therapy in people with multiple sclerosis: An observational case-control studyLaura Moles, Ane Otaegui-Chivite, Miriam Gorostidi-Aicua, et al.
Microorganisms|May 25, 2024
Bacteria-Fungi Interactions in Multiple SclerosisMiriam Gorostidi-Aicua, Iraia Reparaz, Ane Otaegui-Chivite, et al.
Frontiers in Immunology|November 3, 2022
Microbial dysbiosis and lack of SCFA production in a Spanish cohort of patients with multiple sclerosisLaura Moles, Susana Delgado, Miriam Gorostidi-Aicua, et al.
Frontiers in Immunology|August 12, 2025
Exploring the mycobiota in multiple sclerosis: its influence on disease development and progressionAne Otaegui-Chivite, Miriam Gorostidi-Aicua, Laura Martins-Almeida, et al.
Plos One|May 19, 2023
Early biochemical analysis of COVID-19 patients helps severity predictionAndrés Roncancio-Clavijo, Miriam Gorostidi-Aicua, Ainhoa Alberro, et al.
Pageof 1